Gerresheimer firmly on growth track
Düsseldorf (ots) -
- Group revenues climb 9.2 percent to EUR 311.4m in Q3 2012
- Third quarter adjusted EBITDA margin at 19.5 percent
- Net income is EUR 14.4 m, adjusted EPS is EUR 0.62
- Outlook for financial year 2012 confirmed
Gerresheimer AG, one of the leading global partners to the pharma
and healthcare industry, is still on course for growth. 'Our
products, which improve health and well- being, are in high demand
around the globe. Accordingly our revenue growth rates continue to be
high', said Uwe Röhrhoff, CEO of Gerresheimer AG.
Gerresheimer has experienced marked growth in revenues in the
third quarter of the 2012 financial year (December 1, 2011 to
November 30, 2012) of 9.2 percent to EUR 311.4m. At constant exchange
rates growth in revenues was 6.3 percent. All divisions contributed
to this positive development.
'Sales of pharmaceutical plastic packaging products in South
America have developed particularly positively and we have also
achieved good growth in sales of vials, flacons and jars for the
pharmaceutical and cosmetics industries. Demand for self-medication
and diagnostics products such as asthma inhalers, insulin pens and
lancing devices for diabetics is also high,' added Uwe Röhrhoff.
Gerresheimer's operating result (adjusted EBITDA) was EUR 60.8m in
the third quarter of 2012, which is EUR 3.7m or 6.5 percent higher
than the figure for the same quarter of 2011. The adjusted EBITDA
margin was 19.5 percent in the third quarter (prior year 20.0
percent). Net income declined due to one-off effects to EUR 14.4m,
which is EUR 4.8m lower than the prior year quarter's figure. Third
quarter earnings per share of EUR 0.62 were EUR 0.08 slightly lower
than one year ago.
Outlook
Gerresheimer expects the growth of revenues in the financial year
2012 to be unchanged at 9 to 10 percent at constant exchange rates.
The adjusted EBITDA margin forecast also remains the same at 19.5
percent. The company is still expecting the investment volume in the
financial year 2012 to be around EUR 120m.
You can read the complete quarterly report at:
www.gerresheimer.com/en/investor-relations/reports.html
Originaltext: Gerresheimer AG
Digitale Pressemappe: http://www.presseportal.de/pm/9072
Pressemappe via RSS : http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6
Pressekontakt:
Gerresheimer AG
Jens Kürten
Director Corporate Communication & Marketing
Telephone: +4921 1 6181-250
Fax: +49 211 6181-241
E-Mail: j.kuerten@gerresheimer.com
Internet: http://www.gerresheimer.com
Düsseldorf (ots) -
- Group revenues climb 9.2 percent to EUR 311.4m in Q3 2012
- Third quarter adjusted EBITDA margin at 19.5 percent
- Net income is EUR 14.4 m, adjusted EPS is EUR 0.62
- Outlook for financial year 2012 confirmed
Gerresheimer AG, one of the leading global partners to the pharma
and healthcare industry, is still on course for growth. 'Our
products, which improve health and well- being, are in high demand
around the globe. Accordingly our revenue growth rates continue to be
high', said Uwe Röhrhoff, CEO of Gerresheimer AG.
Gerresheimer has experienced marked growth in revenues in the
third quarter of the 2012 financial year (December 1, 2011 to
November 30, 2012) of 9.2 percent to EUR 311.4m. At constant exchange
rates growth in revenues was 6.3 percent. All divisions contributed
to this positive development.
'Sales of pharmaceutical plastic packaging products in South
America have developed particularly positively and we have also
achieved good growth in sales of vials, flacons and jars for the
pharmaceutical and cosmetics industries. Demand for self-medication
and diagnostics products such as asthma inhalers, insulin pens and
lancing devices for diabetics is also high,' added Uwe Röhrhoff.
Gerresheimer's operating result (adjusted EBITDA) was EUR 60.8m in
the third quarter of 2012, which is EUR 3.7m or 6.5 percent higher
than the figure for the same quarter of 2011. The adjusted EBITDA
margin was 19.5 percent in the third quarter (prior year 20.0
percent). Net income declined due to one-off effects to EUR 14.4m,
which is EUR 4.8m lower than the prior year quarter's figure. Third
quarter earnings per share of EUR 0.62 were EUR 0.08 slightly lower
than one year ago.
Outlook
Gerresheimer expects the growth of revenues in the financial year
2012 to be unchanged at 9 to 10 percent at constant exchange rates.
The adjusted EBITDA margin forecast also remains the same at 19.5
percent. The company is still expecting the investment volume in the
financial year 2012 to be around EUR 120m.
You can read the complete quarterly report at:
www.gerresheimer.com/en/investor-relations/reports.html
Originaltext: Gerresheimer AG
Digitale Pressemappe: http://www.presseportal.de/pm/9072
Pressemappe via RSS : http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6
Pressekontakt:
Gerresheimer AG
Jens Kürten
Director Corporate Communication & Marketing
Telephone: +4921 1 6181-250
Fax: +49 211 6181-241
E-Mail: j.kuerten@gerresheimer.com
Internet: http://www.gerresheimer.com